1. Altamura AC, Mauri MC, Cavallaro R, Gorai A (1987) Haloperidol metabolism and anti-psychotic effect in schizophrenia. Lancet 1: 814
2. Altamura AC, Mauri MC, Cavallaro R, Colacurcio F, Gorni A, Bareggi S (1988) Reduced haloperidol/haloperidol ratio and clinical outcome in schizophrenia: preliminary evidences. Prog Neuropsychopharmacol Biol Psychiatry 12 (5):689–694
3. Bigelow LB, Kirch DG, Braun T, Korpi ER, Wagner RL, Zalkman S, Wyatt RJ (1985) Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed dose study. Psychopharmacol Bull 21 (l):66–68
4. Browning JL, Silverman PB, Harrington CA, Davis LM (1982) Preliminary behavioural and pharmacological studies on the haloperidol metabolite reduced haloperidol. Abstr Soc Neurosci 8: 470
5. Cotes PM, Crow TJ, Johnstone EC, Bartlett W, Bourne RC (1978) Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication. Psychol Med 8: 657–665